688180 君实生物-U
已收盘 10-30 15:00:00
资讯
新帖
简况
君实生物(688180)9月30日股东户数3.89万户，较上期增加3.28%
证券之星 · 10-30 19:11
君实生物(688180)9月30日股东户数3.89万户，较上期增加3.28%
君实生物（688180）10月23日主力资金净卖出1917.25万元
证券之星 · 10-24
君实生物（688180）10月23日主力资金净卖出1917.25万元
君实生物（688180）自愿披露JS203联合化疗治疗弥漫大B细胞淋巴瘤III期临床试验完成首例患者给药，10月23日股价上涨4.48%
证券之星 · 10-23
君实生物（688180）自愿披露JS203联合化疗治疗弥漫大B细胞淋巴瘤III期临床试验完成首例患者给药，10月23日股价上涨4.48%
股市必读：君实生物（688180）10月22日董秘有最新回复
证券之星 · 10-23
股市必读：君实生物（688180）10月22日董秘有最新回复
君实生物（688180）10月21日主力资金净买入60.60万元
证券之星 · 10-22
君实生物（688180）10月21日主力资金净买入60.60万元
君实生物（688180）10月8日主力资金净卖出7288.65万元
证券之星 · 10-09
君实生物（688180）10月8日主力资金净卖出7288.65万元
君实生物（688180）披露2026年中期报告，9月28日股价下跌0.11%
证券之星 · 09-28
君实生物（688180）披露2026年中期报告，9月28日股价下跌0.11%
君实生物（688180）披露2025年A股股票期权激励计划预留授予公告，9月24日股价下跌2.52%
证券之星 · 09-24
君实生物（688180）披露2025年A股股票期权激励计划预留授予公告，9月24日股价下跌2.52%
每周股票复盘：君实生物（688180）股东拟减持不超2%股份
证券之星 · 09-06
每周股票复盘：君实生物（688180）股东拟减持不超2%股份
君实生物（688180）披露截至2026年8月31日证券变动月报表，9月3日股价上涨2.03%
证券之星 · 09-03
君实生物（688180）披露截至2026年8月31日证券变动月报表，9月3日股价上涨2.03%
每周股票复盘：君实生物（688180）Q2归母净利润同比增123.75%
证券之星 · 08-30
每周股票复盘：君实生物（688180）Q2归母净利润同比增123.75%
君实生物（688180）2026年中报简析：营收净利润同比双双增长，盈利能力上升
证券之星 · 08-28
君实生物（688180）2026年中报简析：营收净利润同比双双增长，盈利能力上升
君实生物（688180）披露2026年半年度报告，8月27日股价上涨0.25%
证券之星 · 08-27
君实生物（688180）披露2026年半年度报告，8月27日股价上涨0.25%
君实生物(688180.SH)发布半年度业绩，归母净利润2166.3万元，同比扭亏为盈
智通财经 · 08-27
君实生物(688180.SH)发布半年度业绩，归母净利润2166.3万元，同比扭亏为盈
君实生物：上半年净利润2166.3万元 同比扭亏为盈
格隆汇 · 08-26
君实生物：上半年净利润2166.3万元 同比扭亏为盈
君实生物（688180）披露股东减持股份结果公告，8月20日股价上涨8.44%
证券之星 · 08-20
君实生物（688180）披露股东减持股份结果公告，8月20日股价上涨8.44%
港股早盘反复扬升 恒指半日涨1.14% 中国生物制药（01177）涨16.18%
金吾财讯 · 08-20
港股早盘反复扬升 恒指半日涨1.14% 中国生物制药（01177）涨16.18%
每周股票复盘：君实生物（688180）机构连续五日大宗交易净买入超1.8亿
证券之星 · 08-16
每周股票复盘：君实生物（688180）机构连续五日大宗交易净买入超1.8亿
君实生物（688180）披露2026年中期业绩审议董事会会议安排，8月12日股价上涨0.36%
证券之星 · 08-12
君实生物（688180）披露2026年中期业绩审议董事会会议安排，8月12日股价上涨0.36%
君实生物（688180）披露股东减持股份结果公告，8月10日股价下跌0.84%
证券之星 · 08-10
君实生物（688180）披露股东减持股份结果公告，8月10日股价下跌0.84%
加载更多
公司概况
公司名称：
上海君实生物医药科技股份有限公司
所属行业：
医药制造业
上市日期：
2020-07-15
主营业务：
上海君实生物医药科技股份有限公司的主营业务是创新药物的发现和开发、在全球范围内的临床研究、大规模生产到商业化的全产业链。公司的主要产品是拓益®、君迈康®、民得维®、君适达®。公司产品曾荣膺国家专利领域最高奖项“中国专利金奖”，并获得“十二五”、“十三五”两项“重大新药创制”国家重大科技专项支持。
发行价格：
55.50
{"stockData":{"symbol":"688180","market":"SH","secType":"STK","nameCN":"君实生物-U","latestPrice":28.96,"timestamp":1793343600000,"preClose":29.84,"halted":0,"volume":13086401,"delay":0,"changeRate":-0.0295,"floatShares":766000000,"shares":1027000000,"eps":-0.4176,"marketStatus":"已收盘","change":-0.88,"latestTime":"10-30 15:00:00","open":29.34,"high":30.47,"low":28.85,"amount":385000000,"amplitude":0.0543,"askPrice":28.97,"askSize":169,"bidPrice":28.96,"bidSize":87,"shortable":0,"etf":0,"ttmEps":-0.4176,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1793583000000},"marketStatusCode":5,"adr":0,"adjPreClose":29.84,"symbolType":"stock_kcb","openAndCloseTimeList":[[1793323800000,1793331000000],[1793336400000,1793343600000]],"highLimit":32.82,"lowLimit":26.86,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1026689871,"isCdr":false,"pbRate":5.1,"roa":"--","roe":"--","epsLYR":-0.87,"committee":-0.209226,"marketValue":29733000000,"turnoverRate":0.0171,"status":1,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2026-11-02。","afterMarket":{"amount":31856,"volume":1100,"close":28.96,"buyVolume":0,"sellVolume":0,"time":1793345637746,"indexStatus":"已收盘 10-30 15:30:00","preClose":29.84},"hkstockBrief":{"symbol":"01877","market":"HK","secType":"STK","nameCN":"君实生物","latestPrice":15.26,"timestamp":1793347688005,"preClose":15.88,"halted":0,"volume":1833200,"delay":0,"premium":"-55.33"},"floatMarketCap":22195000000},"requestUrl":"/m/hq/s/688180","defaultTab":"news","newsList":[{"id":"2679218044","title":"君实生物(688180)9月30日股东户数3.89万户，较上期增加3.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679218044","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679218044?lang=zh_cn&edition=full","pubTime":"2026-10-30 19:11","pubTimestamp":1793358674,"startTime":"0","endTime":"0","summary":"证券之星消息，近日君实生物披露，截至2026年9月30日公司股东户数为3.89万户，较6月30日增加1238.0户，增幅为3.28%。户均持股数量由上期的2.03万股减少至1.97万股，户均持股市值为70.17万元。在生物制品行业个股中，君实生物股东户数高于行业平均水平，截至9月30日，生物制品行业平均股东户数为3.67万户。从股价来看，2026年6月30日至2026年9月30日，君实生物区间涨幅为5.44%，在此期间股东户数增加1238.0户，增幅为3.28%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103000046498.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK1583","BK1515","01877","688180","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677990316","title":"君实生物（688180）10月23日主力资金净卖出1917.25万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2677990316","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677990316?lang=zh_cn&edition=full","pubTime":"2026-10-24 08:21","pubTimestamp":1792801275,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月23日收盘，君实生物报收于31.69元，上涨4.48%，换手率1.54%，成交量11.78万手，成交额3.62亿元。10月23日的资金流向数据方面，主力资金净流出1917.25万元，占总成交额5.29%，游资资金净流入541.48万元，占总成交额1.5%，散户资金净流入1375.77万元，占总成交额3.8%。融券方面，融券卖出200.0股，融券偿还2602.0股，融券余量33.11万股，融券余额1049.11万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102400006919.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688180","BK0239","BK1583","BK1161","BK1515","01877"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677973656","title":"君实生物（688180）自愿披露JS203联合化疗治疗弥漫大B细胞淋巴瘤III期临床试验完成首例患者给药，10月23日股价上涨4.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2677973656","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677973656?lang=zh_cn&edition=full","pubTime":"2026-10-23 22:38","pubTimestamp":1792766304,"startTime":"0","endTime":"0","summary":"截至2026年10月23日收盘，君实生物报收于31.69元，较前一交易日上涨4.48%，最新总市值为325.36亿元。该股当日开盘30.0元，最高31.75元，最低29.79元，成交额达3.62亿元，换手率为1.54%。近日，上海君实生物医药科技股份有限公司公告，其自主研发的重组人源化抗CD20和CD3双特异性抗体JS203，在复发或难治性弥漫大B细胞淋巴瘤患者中的III期临床试验已完成首例患者给药。此前I期研究显示JS203在R/R B-NHL患者中具有良好的安全性和抗肿瘤活性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102300045791.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["01877","688180","BK1161","BK1515","BK0239","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677995520","title":"股市必读：君实生物（688180）10月22日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2677995520","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677995520?lang=zh_cn&edition=full","pubTime":"2026-10-23 03:27","pubTimestamp":1792697229,"startTime":"0","endTime":"0","summary":"截至2026年10月22日收盘，君实生物报收于30.33元，下跌2.35%，换手率1.0%，成交量7.69万手，成交额2.36亿元。盼你们具体，明确答复。【比如截至到2026年10月9日(星期五）贵公司的股东人数是多少?截至2026年6月30日，公司股东总数为37,720户。截至2026年9月30日公司股东数量请以公司将于2026年10月30日披露的2026年第三季度报告为准。当日关注点交易信息汇总：10月22日主力资金净流出342.5万元，占总成交额1.45%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102300004059.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688180","BK1583","BK1515","BK0239","BK1161","01877"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677947986","title":"君实生物（688180）10月21日主力资金净买入60.60万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2677947986","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677947986?lang=zh_cn&edition=full","pubTime":"2026-10-22 08:20","pubTimestamp":1792628442,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月21日收盘，君实生物报收于31.06元，上涨2.2%，换手率1.33%，成交量10.17万手，成交额3.18亿元。10月21日的资金流向数据方面，主力资金净流入60.6万元，占总成交额0.19%，游资资金净流出106.54万元，占总成交额0.33%，散户资金净流入45.94万元，占总成交额0.14%。融券方面，融券卖出1.42万股，融券偿还200.0股，融券余量31.9万股，融券余额990.67万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102200006751.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688180","BK1515","01877","BK0239","BK1583","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674967889","title":"君实生物（688180）10月8日主力资金净卖出7288.65万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2674967889","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674967889?lang=zh_cn&edition=full","pubTime":"2026-10-09 08:30","pubTimestamp":1791505856,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月8日收盘，君实生物报收于33.42元，下跌6.28%，换手率2.56%，成交量19.64万手，成交额6.71亿元。10月8日的资金流向数据方面，主力资金净流出7288.65万元，占总成交额10.86%，游资资金净流入2370.04万元，占总成交额3.53%，散户资金净流入4918.6万元，占总成交额7.33%。融券方面，融券卖出0.0股，融券偿还2963.0股，融券余量30.35万股，融券余额1014.14万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100900006183.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1161","BK1515","688180","BK1583","BK0239","01877"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670235064","title":"君实生物（688180）披露2026年中期报告，9月28日股价下跌0.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2670235064","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670235064?lang=zh_cn&edition=full","pubTime":"2026-09-28 17:57","pubTimestamp":1790589437,"startTime":"0","endTime":"0","summary":"截至2026年9月28日收盘，君实生物报收于34.84元，较前一交易日下跌0.11%，最新总市值为357.7亿元。该股当日开盘35.31元，最高35.63元，最低34.39元，成交额达3.99亿元，换手率为1.49%。近日，上海君实生物医药科技股份有限公司发布2026年中期报告，报告期内实现收入约人民币16.96亿元，同比增长45%。核心产品拓益国内销售收入达12.99亿元，同比增长36%。公司银行结余及现金合计约36.70亿元，资金状况充裕。报告期内多项产品获海外上市批准，并与复星万邦等达成授权合作。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092800023928.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["01877","BK1161","BK1583","BK0239","BK1515","688180"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669646607","title":"君实生物（688180）披露2025年A股股票期权激励计划预留授予公告，9月24日股价下跌2.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2669646607","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669646607?lang=zh_cn&edition=full","pubTime":"2026-09-24 17:36","pubTimestamp":1790242580,"startTime":"0","endTime":"0","summary":"截至2026年9月24日收盘，君实生物报收于34.88元，较前一交易日下跌2.52%，最新总市值为358.11亿元。君实生物于近日披露《关于向2025年A股股票期权激励计划激励对象授予预留股票期权的公告》。公告显示，公司于2026年9月23日召开第四届董事会第二十三次会议，确定当日为2025年A股股票期权激励计划的预留授权日，向16名激励对象授予71.50万份股票期权，行权价格为46.67元/股。预留授予的等待期分别为12个月和24个月，行权比例分别为50%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092400030387.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["02827","83188","BK1161","BK1610","BK1583","688180","01877","82846","83130","BK1515","159982","03188","02846","07233","BK0239","399300","BK1147","03130"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665636570","title":"每周股票复盘：君实生物（688180）股东拟减持不超2%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2665636570","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665636570?lang=zh_cn&edition=full","pubTime":"2026-09-06 02:49","pubTimestamp":1788634151,"startTime":"0","endTime":"0","summary":"截至2026年9月4日收盘，君实生物报收于33.49元，较上周的33.56元下跌0.21%。本周关注点公司公告汇总：上海檀英计划减持不超20,533,796股，减持比例不超过公司总股本的2%。H股公告：截至2026年8月31日，公司H股与A股股本及已发行股份数目均无变动。公司公告汇总君实生物关于股东减持股份计划的公告：截至公告披露日，上海檀英持有公司38,925,626股，占总股本的3.7914%，股份来源于IPO前取得。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090600000871.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688180","BK1583","BK1515","BK0239","BK1161","01877"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664870185","title":"君实生物（688180）披露截至2026年8月31日证券变动月报表，9月3日股价上涨2.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664870185","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664870185?lang=zh_cn&edition=full","pubTime":"2026-09-03 22:11","pubTimestamp":1788444677,"startTime":"0","endTime":"0","summary":"截至2026年9月3日收盘，君实生物报收于33.75元，较前一交易日上涨2.03%，最新总市值为346.51亿元。近日，上海君实生物医药科技股份有限公司发布截至2026年8月31日的证券变动月报表。公告显示，公司H股和A股的法定/注册股本、已发行股份及库存股份数目均无变动。H股总数为260,295,700股，于港交所上市；A股总数为766,394,171股，于上交所科创板上市。股份期权计划方面，H股及A股股票期权激励计划分别存续13,210,000份和24,700,000份，本月无新增行权或股份变动。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090300042253.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688180","BK1583","01877","161027","BK1515","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663010362","title":"每周股票复盘：君实生物（688180）Q2归母净利润同比增123.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663010362","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663010362?lang=zh_cn&edition=full","pubTime":"2026-08-30 01:44","pubTimestamp":1788025451,"startTime":"0","endTime":"0","summary":"截至2026年8月28日收盘，君实生物报收于33.56元，较上周的37.42元下跌10.32%。本周关注点来自业绩披露要点：2026年第二季度归母净利润4222.71万元，同比上升123.75%。股本股东变化截至2026年6月30日，公司股东户数为3.77万户，较3月31日减少465户，减幅1.22%。户均持股数量由2.01万股增至2.03万股，户均持股市值为68.74万元。负债率为56.68%，毛利率为83.18%，研发投入占营业收入比例为37.96%。公司对截至2026年6月30日的资产进行减值测试，2026年半年度共计计提资产减值准备13,561.59万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083000000574.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["01877","688180"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662036773","title":"君实生物（688180）2026年中报简析：营收净利润同比双双增长，盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2662036773","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662036773?lang=zh_cn&edition=full","pubTime":"2026-08-28 06:18","pubTimestamp":1787869085,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期君实生物发布2026年中报。截至本报告期末，公司营业总收入16.96亿元，同比上升45.18%，归母净利润2166.3万元，同比上升105.25%。本报告期君实生物盈利能力上升，毛利率同比增幅3.9%，净利率同比增幅93.96%。本文数据来源于君实生物2026年中报，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800010947.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["01877","688180"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662223701","title":"君实生物（688180）披露2026年半年度报告，8月27日股价上涨0.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662223701","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662223701?lang=zh_cn&edition=full","pubTime":"2026-08-27 19:27","pubTimestamp":1787830036,"startTime":"0","endTime":"0","summary":"截至2026年8月27日收盘，君实生物报收于35.57元，较前一交易日上涨0.25%，最新总市值为365.19亿元。君实生物于近日披露《2026年半年度报告》。本报告期营业收入为169,621.09万元，同比增长45.18%；利润总额为-3,338.02万元，上年同期为-48,521.16万元；归属于上市公司股东的净利润为2,166.30万元，上年同期为-41,269.56万元；归属于上市公司股东的扣除非经常性损益的净利润为-20,343.85万元，上年同期为-47,842.82万元。研发投入占营业收入的比例为37.96%，上年同期为60.39%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700045876.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1161","688180","BK0239","BK1515","BK1583","01877"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662453607","title":"君实生物(688180.SH)发布半年度业绩，归母净利润2166.3万元，同比扭亏为盈","url":"https://stock-news.laohu8.com/highlight/detail?id=2662453607","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662453607?lang=zh_cn&edition=full","pubTime":"2026-08-27 00:17","pubTimestamp":1787761055,"startTime":"0","endTime":"0","summary":"智通财经APP讯，君实生物 披露2026年半年度报告，报告期公司实现营业收入16.96亿元，同比增长45.18%;归属于上市公司股东的净利润2166.3万元，同比扭亏为盈;归属于上市公司股东的扣除非经常性损益的净利润亏损2.03亿元，同比收窄;基本每股收益0.02元。报告期内，公司在创新药物的发现、研发、生产和商业化等方面皆有源头创新性、突破性进展，现金流情况良好，公司核心管理层及研发团队稳定。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1486610.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688180","01877"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662973587","title":"君实生物：上半年净利润2166.3万元 同比扭亏为盈","url":"https://stock-news.laohu8.com/highlight/detail?id=2662973587","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662973587?lang=zh_cn&edition=full","pubTime":"2026-08-26 18:07","pubTimestamp":1787738862,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0239","688180"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660259400","title":"君实生物（688180）披露股东减持股份结果公告，8月20日股价上涨8.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660259400","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660259400?lang=zh_cn&edition=full","pubTime":"2026-08-20 17:31","pubTimestamp":1787218302,"startTime":"0","endTime":"0","summary":"截至2026年8月20日收盘，君实生物报收于40.45元，较前一交易日上涨8.44%，最新总市值为415.3亿元。公司于近日披露《关于股东减持股份结果公告》。公告显示，本次减持计划实施前，上海檀英持有君实生物59,459,326股，占总股本的5.7914%。因基金期限与流动性资金安排，上海檀英计划通过大宗交易方式减持不超过20,533,797股，减持期间为2026年5月20日至2026年8月19日。减持后持股数量为38,925,626股，持股比例降至3.7914%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082000031138.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1161","688180","BK1583","BK0239","01877","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660944408","title":"港股早盘反复扬升 恒指半日涨1.14% 中国生物制药（01177）涨16.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660944408","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660944408?lang=zh_cn&edition=full","pubTime":"2026-08-20 12:11","pubTimestamp":1787199118,"startTime":"0","endTime":"0","summary":"金吾财讯 | 港股早盘反复扬升，截至午间收盘，恒指涨1.14%，国企指数涨1.42%，恒生科技指数涨1.54%。中国生物制药涨16.18%，石药集团涨13.47%，老铺黄金涨11.39%，周大福涨7.18%，药明生物涨6.47%。毛利率预计由2025年的55%下降至2026年的51%，经调整净利润率亦由14.5%大幅降至7%，相当于约95亿元人民币。海丰国际半日涨6.02%。详细来看，今年上半年归属于上市公司股东的净利润17.12亿元，同比增长2.44%；基本每股收益1.25元。期内实现营业收入130.71亿元，同比增长7.01%。","market":"sg","thumbnail":"https://static.szfiu.com/news/20241108/NzMyOTI2MTc2NzYxOTM1NTM3.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/NzMyOTI2MTc2NzYxOTM1NTM3.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1988792","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1720050803.USD","LU0516423174.USD","LU0543330483.HKD","LU2097828631.EUR","LU0128522157.USD","LU2351347302.SGD","LU2929501877.USD","BK1104","LU0049112450.USD","BK1576","LU0328353924.USD","LU0572940350.SGD","SOCL","LU1951186391.HKD","ZTO","LU2097828557.USD","BK1516","LU0791591158.USD","IE0003851619.USD","LU2279858448.HKD","82800","IE00BYQNZ168.SGD","BK1574","SG9999003461.SGD","LU0072913022.USD","LU2039709279.SGD","07300","02269","HK0000320264.USD","09926","BK1608","IE00B0169L03.USD","IE00BYTNYN87.SGD","LU0463099449.HKD","SG9999001069.SGD","DRGN","BK1141","IE0008368742.USD","LU1152091168.USD","LU1993786604.SGD","LU1251922891.USD","IE0008369823.USD","BK1591","LU1328615791.USD","LU2187417386.USD","SG9999002562.SGD","CRHKY","BK1615","LU0348825331.USD","LU0140636845.USD","LU0708995583.HKD","03033","KURE","01308","BK1607","SG9999001051.SGD","688187","01044","03032","03067","LU2488822045.USD","BK1521","LU1235295612.USD","BK1116","SG9999006514.SGD","02696","LU1226287529.USD","LU1188198961.HKD","BK1515","BK1610","BK1604","BK1588","BK1575","SG9999011746.SGD","01093","03417","IE00B0JY6N72.USD","LU1770034418.SGD","688180","LU0516422440.USD","LU0791590937.USD","LU0181495838.USD","BK1151","LU1366334651.USD","LU0327786744.USD","HK0000165453.HKD","LU3063872942.SGD","LU0315179316.USD","LU0052756011.USD","BK1502","IE00BZ08YT58.USD","LU0516422952.EUR","TCHI","LU0326950275.SGD","IE00B031HY20.USD","LU0314109678.HKD","IE00B543WZ88.USD","HK0000306685.HKD","SG9999004220.SGD","LU0210526637.USD","03419","81024","LU0370786039.SGD","LU1226287792.SGD","LU1226287875.USD","LU1807302812.USD","BK1565","513600","LU0634319403.HKD","SG9999006597.SGD","LU0359202008.SGD","LU0823426308.USD","LU0572939691.SGD","BK1161","LU0348784397.USD","BK1570","LU2097828714.EUR","LU1171460220.USD","02013","LU1303224171.USD","688331","80291","BK1193","LU2097828474.EUR","IE00B29SXG58.USD","09626","BK1578","HK0000288784.HKD","300347","LU1880383366.USD","06181","IE00BZ08YS42.EUR","LU0979878070.USD","HEGIY","IE0034224299.USD","SGXZ90724238.SGD","BK1227","SG9999001093.SGD","HSTECH","LU2097828805.USD","LU1008478684.HKD","SEA","BILI","83115","01929","09088","07200","LU0417516571.SGD","03898","IE00B12V2V27.USD","LU0043850808.USD","LU1969619763.USD","07552","IE00B5MMRT66.SGD","03115","LU0051755006.USD","LU0348766576.USD","LU1688375341.USD","LU0593848301.USD","LU2399975544.HKD","BK1510","BK1589","LU0348783233.USD","LU0067412154.USD","LU0516422366.SGD","LU1366334578.USD","LNVGY","03423","KSTmain","LU0320764599.SGD","LU2328871848.SGD","07500","LU0588546209.SGD","LU0862451837.USD","BK1541","BK1545","BK1171","BK1590","LU2778985437.USD","03037","BK1602","LU0052750758.USD","BK1601","BK1191","03347","HK0000288743.USD","LU0039217434.USD","BK1207","LU0516423091.SGD","LU1961090484.USD","80992","SG9999014674.SGD","IE0031814852.USD","LU0501845795.SGD","07226","LU1242518857.USD","09995","09067","LU0310800965.SGD","LU0128526141.USD","LU0417516738.SGD","BK1500","03088","01024","IE00BPRC5H50.USD","LU0359201885.HKD","LU1769817096.USD","LU0128525689.USD","LU0211977185.USD","LU0048580855.USD","LU0348735423.USD","LU0890818403.SGD","LU1794554557.SGD","01548","LU1046422090.SGD","LU0572944931.SGD","LU1960683339.HKD","00291","LU0244354667.USD","SG9999002463.SGD","00992","LU0264606111.USD","BK1544","BK1224","CJEWY","IE0003795394.USD","02800","02833","BK1587","01877","LU1226288170.HKD","LU0029874061.USD","BK1180","LU2476274720.SGD","SBHMY","LU0456827905.SGD","LU1023057109.AUD","01177","HHImain","LU0029875118.USD","09115","BK1526","LU0417516902.SGD","BK1103","BK1583","IE0003895053.USD","LU0880133367.SGD","WXXWY","LU1328277881.USD","HSI","02057","LU0856984785.SGD","LU1267930227.SGD","LU1769817179.HKD","LU2242644610.SGD","02837","LU1242518931.SGD","LU0348767384.USD","LU0348827113.USD","LU0359201612.USD","HK0000306701.USD","BOAT","LU0307460666.USD","BK1518","LU0456846285.SGD","LU0823426480.USD","LU1719994722.HKD","BK1095","LU0819121731.USD","LU1813983027.USD","LU0540923850.HKD","LU2476274308.USD","IE00BZ08YR35.GBP","LU0320764755.SGD","LU1226288253.USD","BK1618","MCHmain","LU0561508036.HKD","LU0862451753.SGD","LU0672654166.SGD","BK1109","LU1152091754.HKD","IE0032431581.USD","HK0000320223.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659175030","title":"每周股票复盘：君实生物（688180）机构连续五日大宗交易净买入超1.8亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2659175030","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659175030?lang=zh_cn&edition=full","pubTime":"2026-08-16 02:24","pubTimestamp":1786818253,"startTime":"0","endTime":"0","summary":"截至2026年8月14日收盘，君实生物报收于39.89元，较上周的39.24元上涨1.66%。本周关注点来自交易信息汇总：8月10日至14日，君实生物连续五日出现大宗交易，机构合计净买入1.8173亿元。来自股本股东变化：股东上海檀英及贺铭在2026年6月16日至8月10日合计减持1092.26万股，占总股本1.0639%。君实生物H股公告上海君实生物医药科技股份有限公司董事会将于2026年8月26日召开会议，审议本集团截至2026年6月30日止六个月的中期业绩，并处理其他事项。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081600000562.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["01877","BK1161","BK1583","BK1515","688180","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658031029","title":"君实生物（688180）披露2026年中期业绩审议董事会会议安排，8月12日股价上涨0.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2658031029","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658031029?lang=zh_cn&edition=full","pubTime":"2026-08-12 22:10","pubTimestamp":1786543824,"startTime":"0","endTime":"0","summary":"截至2026年8月12日收盘，君实生物报收于38.63元，较前一交易日上涨0.36%，最新总市值为396.61亿元。该股当日开盘38.1元，最高40.56元，最低38.03元，成交额达10.33亿元，换手率为3.42%。近日，君实生物发布公告称，公司董事会谨定于2026年8月26日举行董事会会议，以考虑及通过本集团截至2026年6月30日止六个月的中期业绩，并处理其他事项。本次会议由董事会主席熊俊先生召集。公告同时列出了截至公告日期的董事会成员名单。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081200040029.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1161","BK1515","688180","BK1583","BK0239","01877"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658882932","title":"君实生物（688180）披露股东减持股份结果公告，8月10日股价下跌0.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2658882932","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658882932?lang=zh_cn&edition=full","pubTime":"2026-08-10 22:04","pubTimestamp":1786370699,"startTime":"0","endTime":"0","summary":"截至2026年8月10日收盘，君实生物报收于38.91元，较前一交易日下跌0.84%，最新总市值为399.49亿元。近日，君实生物发布《关于股东减持股份结果公告》。公告显示，本次减持计划实施前，贺铭女士持有公司股份3,531,380股，占公司总股本的0.3440%。因个人资金需求，贺铭女士计划通过集中竞价方式减持不超过882,600股，减持比例不超过公司总股本的0.0860%。本次减持已实施完毕，当前持股数量为2,647,980股，持股比例降至0.2579%。本次减持符合相关法规及此前披露的减持计划。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081000033616.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1161","BK1583","01877","BK1515","BK0239","688180"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1793470494070,"stockEarnings":[{"period":"1week","weight":-0.0861},{"period":"1month","weight":-0.1879},{"period":"3month","weight":-0.2068},{"period":"6month","weight":-0.2828},{"period":"1year","weight":-0.2413},{"period":"ytd","weight":-0.1522}],"compareEarnings":[{"period":"1week","weight":-0.0248},{"period":"1month","weight":-0.0633},{"period":"3month","weight":-0.0609},{"period":"6month","weight":-0.1248},{"period":"1year","weight":-0.0973},{"period":"ytd","weight":-0.0932}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"上海君实生物医药科技股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"38945人(较上一季度增加3.28%)","perCapita":"19678股","listingDate":"2020-07-15","address":"上海市浦东新区中国(上海)自由贸易试验区蔡伦路987号4层","registeredCapital":"102668万元","survey":" 上海君实生物医药科技股份有限公司的主营业务是创新药物的发现和开发、在全球范围内的临床研究、大规模生产到商业化的全产业链。公司的主要产品是拓益®、君迈康®、民得维®、君适达®。公司产品曾荣膺国家专利领域最高奖项“中国专利金奖”，并获得“十二五”、“十三五”两项“重大新药创制”国家重大科技专项支持。","listedPrice":55.5},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"君实生物-U(688180)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供君实生物-U(688180)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"君实生物-U,688180,君实生物-U股票,君实生物-U股票老虎,君实生物-U股票老虎国际,君实生物-U行情,君实生物-U股票行情,君实生物-U股价,君实生物-U股市,君实生物-U股票价格,君实生物-U股票交易,君实生物-U股票购买,君实生物-U股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"君实生物-U(688180)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供君实生物-U(688180)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}